Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Troponin C, fast skeletal muscle (TNNC2), is the calcium-binding component of the troponin complex specific to fast-twitch skeletal muscle fibers[2][3][4]. It functions as the primary **calcium sensor** that regulates striated muscle contraction by binding Ca2+ and transmitting conformational changes that relieve inhibition of actin-myosin interaction[1][2][5]. TNNC2 is composed of four EF-hand domains, of which two N-terminal sites are regulatory (binding Ca2+) and two C-terminal sites are structural (often binding Mg2+ in the resting state)[1]. Upon calcium binding, TNNC2 promotes the displacement of tropomyosin on actin filaments, allowing myosin head attachment and muscle contraction[1][2]. Pathogenic variants can cause rare congenital myopathies, but TNNC2 is most widely recognized for its essential physiological role in rapid skeletal muscle force generation[3][4]. While the fast skeletal isoform is not a routine therapeutic target, its homologs in cardiac tissue (cardiac troponin C) are key clinical biomarkers and drug targets[1]. Drugs such as bepridil interact with troponin C to sensitize Ca2+ binding in cardiac muscle, and similar approaches have been proposed for skeletal isoforms but remain experimental[1]. The troponin C, fast skeletal muscle gene is found on chromosome 20 in humans[3][4].
Calcium sensitization (stabilizing Ca2+-bound conformation to enhance muscle contraction); Modulation of troponin complex activity on the thin filament
1 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Troponin C, fast skeletal muscle (TNNC2).